naringenin has been researched along with acacetin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CJ; Geahlen, RL | 1 |
| Augereau, JM; Billon, M; Gleye, J; Herbert, JM; Lale, A; Leconte, M | 1 |
| Asada, S; Imai, Y; Sugimoto, Y; Tsukahara, S | 1 |
| Domina, NG; Khlebnikov, AI; Kirpotina, LN; Quinn, MT; Schepetkin, IA | 1 |
| Chou, CJ; Frei, N; Grigorov, M; Lo Piparo, E; Scheib, H; Williamson, G | 1 |
| Akamatsu, M; Hosoda, A; Hotta, Y; Ishimoto, Y; Nishizaki, Y; Tamura, H; Yoshikawa, H | 1 |
| Gavande, N; Hanrahan, JR; Hibbs, DE; Kim, MS; Matin, A; Roubin, RH; Salam, NK; Yang, NX | 1 |
| Itoh, T; Sakakibara, H; Shimoi, K; Takemura, H; Yamamoto, K | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Doddareddy, MR; Gavande, N; Groundwater, PW; Hibbs, DE; Matin, A; Nammi, S; Roubin, RH | 1 |
| Atanasov, AG; Dirsch, VM; Heiss, EH; Malainer, C; Mayerhofer, B; Schwaiger, S; Stuppner, H; Tran, TV; Vouk, C; Zimmermann, K | 1 |
| Chaurasiya, ND; Cutler, SJ; Elokely, KM; Gogineni, V; Klein, ML; León, F; Núñez, MJ; Tekwani, BL; Walker, LA | 1 |
| Daikonya, A; Iijima, H; Jiang, WJ; Kitanaka, S; Nemoto, T; Noritake, R; Ohkawara, M; Takamiya, T | 1 |
| Chakraborty, A; Chakraborty, M; Frye, SV; Gu, C; Pearce, KH; Puhl-Rubio, AC; Shears, SB; Stashko, MA; Wang, H; Wang, X | 1 |
| Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
| Fernandes, E; Freitas, M; Porto, G; Ribeiro, D; Silva, AM; Tomé, SM | 1 |
| Cabrita, EJ; Fernandes, E; Freitas, M; Marques, MM; Porto, G; Ribeiro, D; Silva, AM; Tomé, SM | 1 |
1 review(s) available for naringenin and acacetin
| Article | Year |
|---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |
16 other study(ies) available for naringenin and acacetin
| Article | Year |
|---|---|
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
Topics: Amino Acid Sequence; Blood Coagulation; Cell Adhesion; Endotoxins; Flavonoids; Humans; In Vitro Techniques; Interleukin-1; Molecular Sequence Data; Monocytes | 1996 |
Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonoids; Genistein; Humans; K562 Cells; Neoplasm Proteins; Topotecan; Transduction, Genetic; Tritium | 2004 |
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
Topics: Animals; Antioxidants; Drug Design; Flavonoids; Humans; Phagocytes; Phenols; Polyphenols; Quantitative Structure-Activity Relationship | 2007 |
Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase.
Topics: alpha-Amylases; Catalytic Domain; Digestion; Flavones; Flavonols; Humans; Hydrogen Bonding; Ligands; Models, Molecular; Protein Conformation; Saliva; Starch; Structure-Activity Relationship | 2008 |
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
Topics: Androgen Receptor Antagonists; Androgens; Cell Line, Tumor; Flavonoids; Genes, Reporter; Humans; Receptors, Androgen; Receptors, Glucocorticoid; Structure-Activity Relationship | 2009 |
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Topics: Benzopyrans; Cell Line; Humans; PPAR alpha; PPAR gamma; Structure-Activity Relationship | 2009 |
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Flavonoids; Humans; Models, Molecular; Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists.
Topics: Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; HEK293 Cells; Humans; Isoflavones; Models, Molecular; Molecular Structure; Peroxisome Proliferator-Activated Receptors; Structure-Activity Relationship | 2013 |
Identification of chromomoric acid C-I as an Nrf2 activator in Chromolaena odorata.
Topics: Cell Culture Techniques; Cell Survival; Chromolaena; Fatty Acids, Unsaturated; Furans; Heme Oxygenase-1; Inflammation; Luciferases; Molecular Structure; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-E2-Related Factor 2; Plant Leaves; Vietnam | 2014 |
Isolation of Acacetin from Calea urticifolia with Inhibitory Properties against Human Monoamine Oxidase-A and -B.
Topics: Asteraceae; Catalytic Domain; Dose-Response Relationship, Drug; El Salvador; Flavones; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Monoamine Oxidase Inhibitors; Structure-Activity Relationship; Time Factors | 2016 |
Structure-activity relationship of the inhibitory effects of flavonoids on nitric oxide production in RAW264.7 cells.
Topics: Animals; Biological Products; Dose-Response Relationship, Drug; Flavonoids; Mice; Models, Molecular; Molecular Structure; Nitric Oxide; RAW 264.7 Cells; Rhodiola; Sophora; Structure-Activity Relationship | 2017 |
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
Topics: Binding Sites; Crystallography, X-Ray; HCT116 Cells; Humans; Inositol Phosphates; Molecular Structure; Phosphotransferases (Alcohol Group Acceptor); Phosphotransferases (Phosphate Group Acceptor); Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quercetin; Structure-Activity Relationship | 2019 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |
Modulation of human neutrophils' oxidative burst by flavonoids.
Topics: Flavonoids; Humans; Luminescent Measurements; Molecular Structure; Neutrophils; Oxidation-Reduction | 2013 |
Inhibition of LOX by flavonoids: a structure-activity relationship study.
Topics: Dose-Response Relationship, Drug; Flavonoids; Glycine max; Humans; Leukotriene B4; Lipoxygenase; Molecular Structure; Neutrophils; Structure-Activity Relationship | 2014 |